Zenosense, Inc. (ZENO) Early Detection Systems for MRSA/SA & Lung Cancer Proactively Address Massive Global Market
In the case of most progressive illnesses, early detection is key, and this is particularly true for both primary types of lung cancer, NSCLC and SCLC (non-small cell lung cancer and small cell lung cancer), as well as the "Super Bug" known as MRSA (Methicillin-resistant Staphylococcus aureus). MRSA, a kind of robust and highly persistent staph bacterium, is a major, growing concern for hospitals, due in large part to this nasty little bug's ability to shrug off the most powerful antibiotics available today. Whether a given infection is technically classified as a CA-MRSA (community-acquired) or HA-MRSA (hospital-acquired), the patient end…